We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
12.2 quarters
Top 10 Avg Time Held
6.4 quarters
Top 20 Avg Time Held
8.5 quarters

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH icon
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 16.24%
3 Technology 15.4%
4 Industrials 13.98%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.04T
$174M 2.55%
4,113,916
+61,924
+2% +$2.59M
2013 Q2
18 quarters
MSFT icon
2
Microsoft
MSFT
$4.03T
$156M 2.29%
1,824,605
-6,969
-0.4% -$572K
2013 Q2
18 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.31T
$139M 2.04%
2,653,940
+37,240
+1% +$1.9M
2013 Q2
18 quarters
JPM icon
4
JPMorgan Chase
JPM
$872B
$121M 1.78%
1,132,902
+21,339
+2% +$2.16M
2013 Q2
18 quarters
JNJ icon
5
Johnson & Johnson
JNJ
$602B
$113M 1.66%
810,344
+5,772
+0.7% +$804K
2013 Q2
18 quarters
BDX icon
6
Becton Dickinson
BDX
$51.6B
$112M 1.64%
537,251
+70,478
+15% +$14.8M
2013 Q2
18 quarters
MMM icon
7
3M
MMM
$84.1B
$109M 1.59%
551,620
-4,149
-0.7% -$798K
2013 Q2
18 quarters
ACN icon
8
Accenture
ACN
$132B
$106M 1.55%
690,980
-3,392
-0.5% -$492K
2016 Q1
7 quarters
COST icon
9
Costco
COST
$427B
$96.1M 1.41%
516,412
-2,475
-0.5% -$427K
2013 Q2
18 quarters
ITW icon
10
Illinois Tool Works
ITW
$76.1B
$92.9M 1.36%
556,593
-4,767
-0.8% -$760K
2013 Q2
18 quarters
CMCSA icon
11
Comcast
CMCSA
$74B
$90.8M 1.33%
2,268,372
+7,810
+0.3% +$294K
2013 Q2
18 quarters
PNC icon
12
PNC Financial Services
PNC
$85.8B
$89.4M 1.31%
619,808
+5,528
+0.9% +$764K
2013 Q2
18 quarters
V icon
13
Visa
V
$739B
$89.3M 1.31%
783,579
-1,093
-0.1% -$121K
2013 Q2
18 quarters
ATR icon
14
AptarGroup
ATR
$7.6B
$85.1M 1.25%
986,274
+38,201
+4% +$3.33M
2013 Q2
18 quarters
USB icon
15
US Bancorp
USB
$87.3B
$81.9M 1.2%
1,528,230
+2,420
+0.2% +$130K
2013 Q3
17 quarters
ADP icon
16
Automatic Data Processing
ADP
$110B
$81.8M 1.2%
697,884
-4,849
-0.7% -$554K
2013 Q2
18 quarters
ORCL icon
17
Oracle
ORCL
$417B
$78.6M 1.15%
1,661,875
+16,453
+1% +$807K
2013 Q2
18 quarters
UNP icon
18
Union Pacific
UNP
$169B
$77.3M 1.13%
576,317
-1,735
-0.3% -$209K
2013 Q2
18 quarters
NKE icon
19
Nike
NKE
$52.4B
$74.2M 1.09%
1,185,503
-26,266
-2% -$1.51M
2013 Q2
18 quarters
UNH icon
20
UnitedHealth
UNH
$351B
$71.2M 1.04%
323,084
+850
+0.3% +$180K
2016 Q1
7 quarters
HUBB icon
21
Hubbell
HUBB
$25.1B
$68.2M 1%
503,745
+4,056
+0.8% +$506K
2015 Q4
8 quarters
CSCO icon
22
Cisco
CSCO
$454B
$65.7M 0.96%
1,716,207
+188,145
+12% +$6.72M
2013 Q2
18 quarters
PEP icon
23
PepsiCo
PEP
$174B
$65M 0.95%
541,702
-3,876
-0.7% -$443K
2013 Q2
18 quarters
ROST icon
24
Ross Stores
ROST
$72.8B
$63.9M 0.94%
795,672
-17,095
-2% -$1.2M
2013 Q2
18 quarters
SYK icon
25
Stryker
SYK
$109B
$63.7M 0.93%
411,536
-16,071
-4% -$2.45M
2013 Q2
18 quarters
1
2 3 4 5

Similar funds

MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.